Best Practice & Research Clinical Haematology
Volume 19, Issue 4 , Pages 795-810 , December 2006

Alemtuzumab in T-cell lymphoproliferative disorders

  • Claire E. Dearden, BSc, MD, FRCP, FRCPath (Consultant Haematologist)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 20 8661 3655; Fax: +44 20 8642 9634.
    • ,
  • Estella Matutes, MD, PhD, FRCPath (Consultant Haematologist)

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(06)00037-5

doi: 10.1016/j.beha.2006.05.005

Best Practice & Research Clinical Haematology
Volume 19, Issue 4 , Pages 795-810 , December 2006

Article Tools

* Image Usage & Resolution